Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015

DUBLIN, July 27, 2015 /CNW/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its second quarter 2015 financial results before the open of the U.S. financial markets on August 10, 2015 and members of its senior management team will host a conference call and webcast at 8:00 a.m. ET that day. 

The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the conference number is 93183256. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from August 10, 2015 at 11:00 a.m. ET until 11:59 p.m. ET on August 24, 2015 by dialing (855) 859-2056 (U.S./Canada) or (404) 537-3406 (International) and entering the conference number is 93183256.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on August 24, 2015. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo International plc
Endo International plc is a global specialty healthcare company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical, generic pharmaceutical, over-the-counter medications and medical device products through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-second-quarter-2015-financial-results-on-august-10-2015-300118795.html

SOURCE Endo International plc

Investors/Media: Keri P. Mattox, (484) 216-7912; Investors: Jonathan Neely, (484) 216-6645; Media: Heather Zoumas-Lubeski, (484) 216-6829, http://www.endo.comCopyright CNW Group 2015
Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today